BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pang TC, Lam VW. Surgical management of hepatocellular carcinoma. World J Hepatol 2015; 7(2): 245-252 [PMID: 25729479 DOI: 10.4254/wjh.v7.i2.245]
URL: https://www.wjgnet.com/1007-9327/full/v7/i2/245.htm
Number Citing Articles
1
Ying Zhang, Tao Li, Yumin Qiu, Tao Zhang, Pengbo Guo, Xiaomin Ma, Qing Wei, Lihui Han. Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinomaMedicine 2017; 96(2): e5642 doi: 10.1097/MD.0000000000005642
2
Michelle Ju, Adam C. Yopp. The Utility of Anatomical Liver Resection in Hepatocellular Carcinoma: Associated with Improved Outcomes or Lack of Supportive Evidence?Cancers 2019; 11(10): 1441 doi: 10.3390/cancers11101441
3
Michelle R. Ju, Adam C. Yopp. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experienceAnnals of Gastroenterological Surgery 2020; 4(3): 208 doi: 10.1002/ags3.12316
4
Peng Sheng Yi, Yong Li, Shu Yan, Bin Wu, Chuan Lan, Jian Shui Li. Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinomaScandinavian Journal of Gastroenterology 2019; 54(2): 240 doi: 10.1080/00365521.2019.1577487
5
Ahmed Omar Kaseb, Luis Vence, Jorge Blando, Shalini S. Yadav, Naruhiko Ikoma, Roberto Carmagnani Pestana, Jean Nicolas Vauthey, James P. Allison, Padmanee Sharma. Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular CarcinomaCancer Immunology Research 2019; 7(9): 1390 doi: 10.1158/2326-6066.CIR-18-0605
6
Guang-Tao Min, Yu-Min Li, Nan Yao, Jun Wang, Hong-Peng Wang, Wei Chen. The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysisClinical Transplantation 2018; 32(1): e13151 doi: 10.1111/ctr.13151
7
Xiaoqin Wu, Bin Zhao, Yahui Cheng, Yang Yang, Cheng Huang, Xiaoming Meng, Baoming Wu, Lei Zhang, Xiongwen Lv, Jun Li. Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cellsToxicology and Applied Pharmacology 2015; 288(1): 74 doi: 10.1016/j.taap.2015.07.010
8
Keisuke Arai, Takumi Fukumoto, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Hisoka Kinoshita, Shohei Komatsu, Daisuke Tsugawa, Sachio Terai, Taku Matsumoto, Tadahiro Goto, Sadaki Asari, Hirochika Toyama, Tetsuo Ajiki, Yonson Ku. Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysisSurgery Today 2017; 47(3): 385 doi: 10.1007/s00595-016-1384-7
9
Keunyoung Kim, Seong-Jang Kim. Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysisClinical Imaging 2021; 79: 251 doi: 10.1016/j.clinimag.2021.06.015
10
Horatio R. Thomas, Mary Feng. Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular CarcinomaCurrent Hepatology Reports 2021; 20(1): 12 doi: 10.1007/s11901-020-00559-1
11
Marwa Matboli, Ayman E Shafei, Mahmoud A Ali, Ahmed M Ashry, Kamal M Kamal, Mohammed Ali Agag, Ibrahim Reda, Eman Fathy Tash, Marwa Ali. circRNAs (hsa_circ_00156, hsa_circ _000224, and hsa_circ _000520) are novel potential biomarkers in hepatocellular carcinomaJournal of Cellular Biochemistry 2019; 120(5): 7711 doi: 10.1002/jcb.28045
12
Gonzalo Sapisochin, Jordi Bruix. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approachesNature Reviews Gastroenterology & Hepatology 2017; 14(4): 203 doi: 10.1038/nrgastro.2016.193
13
Arno Kornberg, Martina Schernhammer, Helmut Friess. 18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular CarcinomaJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00014
14
Francesco Vasuri, Michela Visani, Giorgia Acquaviva, Thomas Brand, Michelangelo Fiorentino, Annalisa Pession, Giovanni Tallini, Antonia D’Errico, Dario de Biase. Role of microRNAs in the main molecular pathways of hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(25): 2647-2660 doi: 10.3748/wjg.v24.i25.2647
15
Che-Yu Hsu, Chun-Wei Wang, Ann-Lii Cheng, Sung-Hsin Kuo. Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectivenessWorld Journal of Gastrointestinal Oncology 2019; 11(8): 579-588 doi: 10.4251/wjgo.v11.i8.579
16
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
17
Po-Chien Shen, Wei-Chou Chang, Cheng-Hsiang Lo, Jen-Fu Yang, Meei-Shyuan Lee, Yang-Hong Dai, Chun-Shu Lin, Chao-Yueh Fan, Wen-Yen Huang. Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular CarcinomaInternational Journal of Radiation Oncology*Biology*Physics 2019; 105(2): 307 doi: 10.1016/j.ijrobp.2019.05.066
18
Yuan Zhang, Min Ding, Jia-chang Chi, Tao Wang, Yao-ping Shi, Bo Zhai. The early evaluation of ultrasound-guided iodine-125 interstitial implants for high-risk hepatocellular carcinomaBrachytherapy 2019; 18(5): 733 doi: 10.1016/j.brachy.2019.05.011
19
Nicole Nevarez, Adam Yopp. Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor ThrombusJournal of Hepatocellular Carcinoma 2021; : 851 doi: 10.2147/JHC.S291530
20
Keisuke Arai, Takumi Fukumoto, Motofumi Tanaka, Kaori Kuramitsu, Masahiro Kido, Hisoka Kinoshita, Taku Matsumoto, Hirochika Toyama, Sadaki Asari, Tadahiro Goto, Tetsuo Ajiki, Yonson Ku. Pathological complete response after percutaneous isolated hepatic perfusion in hepatocellular carcinoma with portal vein tumor thrombosis: a case reportSurgical Case Reports 2016; 2(1) doi: 10.1186/s40792-016-0178-x
21
Yujia Xia, Zachary J. Brown, Hai Huang, Allan Tsung. Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinomaCancer Medicine 2021; 10(18): 6374 doi: 10.1002/cam4.4177
22
Zheng-Guang Xu, Cheng-Jie Ye, Lin-Xun Liu, Gang Wu, Zhan-Xue Zhao, Yong-Zhen Wang, Bing-Qiang Shi, Yong-Hong Wang. The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysisBiomarkers in Medicine 2018; 12(2): 189 doi: 10.2217/bmm-2017-0307
23
Alyson P Black, Anand S Mehta. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcomeCurrent Opinion in Pharmacology 2018; 41: 74 doi: 10.1016/j.coph.2018.04.002
24
Joseph Asemota, Mohammed Saleh, Osato Igbinovia, Danny Burns. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular CarcinomaCureus 2020;  doi: 10.7759/cureus.9191
25
Connor A. West, Alyson P. Black, Anand S. Mehta. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 93 doi: 10.1007/978-3-030-21540-8_5
26
Stacey Prenner, Laura Kulik. Zakim and Boyer's Hepatology2018; : 668 doi: 10.1016/B978-0-323-37591-7.00046-X
27
Yunjiao Wang, Chuchu Peng, Zhigang Cheng, Ximei Wang, Lei Wu, Jingyi Li, Changsheng Huang, Qulian Guo, Hongwei Cai. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysisInternational Journal of Surgery 2018; 55: 73 doi: 10.1016/j.ijsu.2018.05.022
28
Young-In Yoon, Sung-Gyu Lee. Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian PerspectiveDigestive Diseases and Sciences 2019; 64(4): 993 doi: 10.1007/s10620-019-05551-4
29
G.K. Glantzounis, E. Tokidis, S.-P. Basourakos, E.E. Ntzani, G.D. Lianos, G. Pentheroudakis. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic reviewEuropean Journal of Surgical Oncology (EJSO) 2017; 43(1): 32 doi: 10.1016/j.ejso.2016.05.026
30
Yu-De Chu, Hsin-Yu Lai, Li-Mei Pai, Ya-Hui Huang, Yang-Hsiang Lin, Kung-Hao Liang, Chau-Ting Yeh. The methionine salvage pathway-involving ADI1 inhibits hepatoma growth by epigenetically altering genes expression via elevating S-adenosylmethionineCell Death & Disease 2019; 10(3) doi: 10.1038/s41419-019-1486-4
31
Anuradha Budhu, Xin Wei Wang. Hepatocellular Carcinoma2016; : 93 doi: 10.1007/978-3-319-34214-6_5
32
Jeffrey S. Morris, Manal M. Hassan, Ye Emma Zohner, Zeya Wang, Lianchun Xiao, Asif Rashid, Abedul Haque, Reham Abdel‐Wahab, Yehia I. Mohamed, Karri L. Ballard, Robert A. Wolff, Bhawana George, Liang Li, Genevera Allen, Michael Weylandt, Donghui Li, Wenyi Wang, Kanwal Raghav, James Yao, Hesham M. Amin, Ahmed Omar Kaseb. HepatoScore ‐14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk Hepatology 2021; 73(6): 2278 doi: 10.1002/hep.31555
33
Yufei Tian, Wei Yao, Dongyun He, Yingying Xu, Yiquan Li, Yilong Zhu, Jinbo Fang, Bing Bai, Xiao Li, Lili Sun, Ningyi Jin. A dual cancer-specific recombinant adenovirus suppresses the growth of liver cancer cells in vivo and in vitroAnti-Cancer Drugs 2020; 31(2): 110 doi: 10.1097/CAD.0000000000000854
34
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Gueralp O. Ceyhan, Katharina Mueller, Helmut Friess, Katharina Thrum. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14430-9
35
Hae Won Lee, Kyung-Suk Suh. Expansion of the criteria for living donor liver transplantation for hepatocellular carcinomaCurrent Opinion in Organ Transplantation 2016; 21(2): 231 doi: 10.1097/MOT.0000000000000294
36
Pegah Golabi, Sofie Fazel, Munkhzul Otgonsuren, Mehmet Sayiner, Cameron T. Locklear, Zobair M. Younossi. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalitiesMedicine 2017; 96(9): e5904 doi: 10.1097/MD.0000000000005904
37
Jian-Feng Yang, Zhen-Hua Zhao, Yu Zhang, Li Zhao, Li-Ming Yang, Min-Ming Zhang, Bo-Yin Wang, Ting Wang, Bao-Chun Lu. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(13): 3652-3662 doi: 10.3748/wjg.v22.i13.3652
38
Soo-Ho Lee, Jun-Suh Lee, Gun-Hyung Na, Young-Kyoung You, Dong-Goo Kim. Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantationClinical Transplantation 2017; 31(1): e12852 doi: 10.1111/ctr.12852
39
Takayuki Shimizu, Mitsuru Ishizuka, Takashi Suzuki, Genki Tanaka, Kyung Hwa Park, Takatsugu Matsumoto, Takayuki Shiraki, Yuhki Sakuraoka, Masato Kato, Taku Aoki, Keiichi Kubota. The preoperative globulin-to-albumin ratio, a novel inflammation-based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinomaJournal of Surgical Oncology 2017; 116(8): 1166 doi: 10.1002/jso.24772
40
HJ Lim, AKH Chiow, LS Lee, SS Tan, BKP Goh, YX Koh, CY Chan, SY Lee. Novel method of intraoperative liver tumour localisation with indocyanine green and near-infrared imagingSingapore Medical Journal 2021; 62(4): 182 doi: 10.11622/smedj.2019137
41
Jin Shang, Shanling Xu, Jiaxing Zhang, Xuting Ran, Lang Bai, Hong Tang. Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysisOncotarget 2017; 8(65): 109723 doi: 10.18632/oncotarget.21299
42
Xionghu Shen, Xian Cui, Hai Cui, Yongmin Jin, Wenbiao Jin, Honghua Sun. Geraniol and lupeol inhibit growth and promote apoptosis in human hepatocarcinoma cells through the MAPK signaling pathwayJournal of Cellular Biochemistry 2019; 120(4): 5033 doi: 10.1002/jcb.27779